Agilon Health Inc. (NYSE: AGL) reported Q2 EPS of ($0.05), $0.03 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $670 million versus the consensus estimate of $648.13 million.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.